152 related articles for article (PubMed ID: 19387612)
1. Translating TCF7L2: from gene to function.
Pearson ER
Diabetologia; 2009 Jul; 52(7):1227-30. PubMed ID: 19387612
[No Abstract] [Full Text] [Related]
2. TCF7L2: the biggest story in diabetes genetics since HLA?
Zeggini E; McCarthy MI
Diabetologia; 2007 Jan; 50(1):1-4. PubMed ID: 17096114
[No Abstract] [Full Text] [Related]
3. Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects.
Field SF; Howson JM; Smyth DJ; Walker NM; Dunger DB; Todd JA
Diabetologia; 2007 Jan; 50(1):212-3. PubMed ID: 17063324
[No Abstract] [Full Text] [Related]
4. TCF7L2 and type 2 diabetes--we WNT to know.
Smith U
Diabetologia; 2007 Jan; 50(1):5-7. PubMed ID: 17102948
[No Abstract] [Full Text] [Related]
5. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function.
Gloyn AL; Braun M; Rorsman P
Diabetes; 2009 Apr; 58(4):800-2. PubMed ID: 19336690
[No Abstract] [Full Text] [Related]
6. [Important diabetes gene detected].
Bürger J
Versicherungsmedizin; 2006 Jun; 58(2):94. PubMed ID: 16800149
[No Abstract] [Full Text] [Related]
7. Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects.
Miyake K; Horikawa Y; Hara K; Yasuda K; Osawa H; Furuta H; Hirota Y; Yamagata K; Hinokio Y; Oka Y; Iwasaki N; Iwamoto Y; Yamada Y; Seino Y; Maegawa H; Kashiwagi A; Yamamoto K; Tokunaga K; Takeda J; Makino H; Nanjo K; Kadowaki T; Kasuga M
J Hum Genet; 2008; 53(2):174-180. PubMed ID: 18097733
[TBL] [Abstract][Full Text] [Related]
8. Open chromatin and diabetes risk.
Groop L
Nat Genet; 2010 Mar; 42(3):190-2. PubMed ID: 20179731
[No Abstract] [Full Text] [Related]
9. The accelerator hypothesis cannot be tested using the type 2 diabetes gene, TCF7L2.
Wilkin TJ
Diabetologia; 2007 Aug; 50(8):1780. PubMed ID: 17589824
[No Abstract] [Full Text] [Related]
10. An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
van de Bunt M
Diabetologia; 2016 Nov; 59(11):2292-2294. PubMed ID: 27623948
[No Abstract] [Full Text] [Related]
11. Common coding variant in the TCF7L2 gene and study of the association with type 2 diabetes in Japanese subjects.
Kunika K; Tanahashi T; Numata S; Ueno SI; Ohmori T; Nakamura N; Tsugawa K; Miyawaki K; Moritani M; Inoue H; Itakura M
J Hum Genet; 2008; 53(11-12):972-982. PubMed ID: 19012045
[TBL] [Abstract][Full Text] [Related]
12. TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population.
Marquezine GF; Pereira AC; Sousa AG; Mill JG; Hueb WA; Krieger JE
BMC Med Genet; 2008 Dec; 9():106. PubMed ID: 19055834
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes.
Yu J; Steck AK; Babu S; Yu L; Miao D; McFann K; Hutton J; Eisenbarth GS; Klingensmith G
J Clin Endocrinol Metab; 2009 Feb; 94(2):504-10. PubMed ID: 19050058
[TBL] [Abstract][Full Text] [Related]
14. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis.
Tong Y; Lin Y; Zhang Y; Yang J; Zhang Y; Liu H; Zhang B
BMC Med Genet; 2009 Feb; 10():15. PubMed ID: 19228405
[TBL] [Abstract][Full Text] [Related]
15. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
Jin T; Liu L
Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
[TBL] [Abstract][Full Text] [Related]
16. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort.
van Vliet-Ostaptchouk JV; Shiri-Sverdlov R; Zhernakova A; Strengman E; van Haeften TW; Hofker MH; Wijmenga C
Diabetologia; 2007 Jan; 50(1):59-62. PubMed ID: 17031610
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
18. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population.
González-Sánchez JL; Martínez-Larrad MT; Zabena C; Pérez-Barba M; Serrano-Ríos M
Diabetologia; 2008 Nov; 51(11):1993-7. PubMed ID: 18712344
[TBL] [Abstract][Full Text] [Related]
19. Prime suspect: the TCF7L2 gene and type 2 diabetes risk.
Hattersley AT
J Clin Invest; 2007 Aug; 117(8):2077-9. PubMed ID: 17671643
[TBL] [Abstract][Full Text] [Related]
20. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.
Haupt A; Thamer C; Heni M; Ketterer C; Machann J; Schick F; Machicao F; Stefan N; Claussen CD; Häring HU; Fritsche A; Staiger H
Diabetes; 2010 Mar; 59(3):747-50. PubMed ID: 20028944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
